: FDA approves Alzheimer’s treatment Leqembi, clearing the way for Medicare coverage

Despite Medicare coverage, drug may remain out of reach for many patients, policy experts say 

Previous post The Ratings Game: Chip stocks lag market as semiconductor sales decline for 11th straight month
Next post : This ‘Thread’ social platform existed years before Meta’s new app — and it could sue, experts say